<?xml version="1.0"?>
<!DOCTYPE TimeML SYSTEM "TimeML.dtd">
<TimeML>
In a report issued on <TIMEX3 tid="t2" type="DATE" value="2017-01-27">January 27</TIMEX3>, Liana Moussatos from Wedbush reiterated a Buy rating on United Therapeutics (NASDAQ: UTHR ), with a price target of $229 . The company’s shares closed <TIMEX3 tid="t3" type="DATE" value="2017-01-27">last Friday</TIMEX3> at $162.43, close to its <TIMEX3 tid="t5" type="DURATION" value="P52W">52-week</TIMEX3> high of $162.92. 
 
According to TipRanks.com , Moussatos is a 5-star analyst with an average return of 11.0% and a 41.9% success rate. Moussatos covers the Healthcare sector, focusing on stocks such as Catabasis Pharmaceuticals, Lexicon Pharmaceuticals, and Pacira Pharmaceuticals. 
 
United Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $229. 
 
Based on United Therapeutics’ latest earnings report for <TIMEX3 tid="t7" type="DATE" value="2017-Q1">the quarter</TIMEX3> ending <TIMEX3 tid="t8" type="DATE" value="2017-09-30">September 30</TIMEX3>, the company posted quarterly revenue of $408 million and quarterly net profit of $162 million. In comparison, <TIMEX3 tid="t9" type="DATE" value="2016">last year</TIMEX3> the company earned revenue of $405 million and had  a net profit of $105 million. 
 
Based on the <TIMEX3 tid="t10" type="DATE" value="PAST_REF">recent</TIMEX3> corporate insider activity of 96 insiders, corporate insider sentiment is negative on the stock.  Most <TIMEX3 tid="t13" type="DATE" value="PAST_REF">recently</TIMEX3>, in <TIMEX3 tid="t14" type="DATE" value="2016-12">December 2016</TIMEX3>, Richard Giltner, a Director at UTHR sold 5,000 shares for a total of $666,800. 
 
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. 
 
United Therapeutics Corp. operates as a biotechnology company. The company is engaged in development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases. United Therapeutics was founded by Martine A. Rothblatt on <TIMEX3 tid="t17" type="DATE" value="1996-06-26">June 26, 1996</TIMEX3> and is headquartered in Silver <TIMEX3 tid="t19" type="DATE" value="2017-SP">Spring</TIMEX3>, MD. 
 


The post appeared first on Analyst Ratings .
</TimeML>
